M&A Deal Summary

CBMG Holdings Acquires Agreen Biotech

On September 30, 2014, CBMG Holdings acquired life science company Agreen Biotech for 3M USD

Acquisition Highlights
  • This is CBMG Holdings’ 1st transaction in the Life Science sector.
  • This is CBMG Holdings’ largest (disclosed) transaction.
  • This is CBMG Holdings’ 1st transaction in China.

M&A Deal Summary
Date 2014-09-30
Target Agreen Biotech
Sector Life Science
Buyer(s) CBMG Holdings
Deal Type Add-on Acquisition
Deal Value 3M USD

Target

Agreen Biotech

China
Agreen Biotech Co. Ltd. is a provider of T Cells Receptor ("TCR") clonality analysis technology and T Central Memory Cell ("Tcm") and Dendritic Cell ("DC") preparation methodologies.

Search 200,197 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

CBMG Holdings

Rockville, Maryland, United States
Category Company
Founded 2001
Sector Life Science
Employees217
DESCRIPTION

CBMG Holdings is a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancer and stem cell therapies for degenerative diseases. CBMG Holdings was founded in 2001 and is based in Rockville, Maryland.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (China) 1 of 1
Year (2014) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal